Reproductive Endocrinology & Infertility Research
The Division of Reproductive Endocrinology & Infertility at the University of Illinois Hospital & Health Sciences System is dedicated to providing state-of-the-art fertility treatments for couples who have been unable to achieve a successful pregnancy, and, to advance our knowledge of reproductive disorders through ground-breaking translational research. The Division consists of nationally recognized physicians and scientists who are at the forefront of infertility and pregnancy loss evaluation and management and the understanding of reproductive disorders.
The Division’s clinical research covers many aspects of infertility and recurrent pregnancy loss, including studies on assisted reproductive technology impact on couples with infertility, long term consequences of fertility medication on women’s health, and the genomics of miscarriage. The Division also conducts molecular research on endometrial factors affecting embryo implantation.
This combination of clinical and research endeavors in the Division of Reproductive Endocrinology and Infertility provides a unique opportunity to meet the needs of the most unique patients with reproductive issues.
The Division is seeking funding to promote studies in patients with infertility and recurrent pregnancy loss and to remain at the forefront of reproductive research. This is a summary of ongoing projects in the areas of infertility and reproduction.
Division Research Projects
Frank González, MD
- Treating Inflammation to Ameliorate Ovarian Dysfunction in PCOS – A Randomized Controlled Trial of Nonsteroidal Anti-inflammatory Therapy
Humberto ‘Bert’ Scoccia, MD
- Investigational Oocyte Cryopreservation for Medical and Nonmedical Indicators
- Extended Follow-up of Women Evaluated and Treated for Infertility
- Oncofertility consortium ovarian tissue cryopreservation
- Impact of Endometrial Scratching and Chronic Endometritis on IVF Pregnancy and Pregnancy Loss Rates
- Genomic Changes in Human Miscarriages and their Functional Consequences
- Optimal treatment for women with a Persisting Pregnancy of Unknown Location – a Randomized Clinical Trial of women at risk for an ectopic pregnancy: Active Treatment versus No Treatment. The “ACT orNOT TRIAL”
- University of Illinois Reproductive Loss Project (RLP)
Nicola Winston, Ph.D.
- Assessment of factors involved in the regulation of human oocyte maturation
8) Fertility preservation decisions among young women with a life threatening illness.
Investigational oocyte cryopreservation (egg freezing) for medical and non medical indications.
Frank González, MD